カテゴリー： Market Monitor Global, 世界, 医療/バイオ

CAR T細胞型薬剤の世界市場見通し2023年-2029年

◆英語タイトル：Drugs Based on CAR T-cell Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8484 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：61 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Drugs Based on CAR T-cell Market 調査レポートは次の情報を含め、グローバルにおけるのCAR T細胞型薬剤市場規模と予測を収録しています。・世界のCAR T細胞型薬剤市場：売上、2018年-2023年、2024年-2029年
・世界のCAR T細胞型薬剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のCAR T細胞型薬剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CD19標的」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

CAR T細胞型薬剤のグローバル主要企業は、Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKiteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、CAR T細胞型薬剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のCAR T細胞型薬剤市場：タイプ別、2018年-2023年、2024年-2029年
世界のCAR T細胞型薬剤市場：タイプ別市場シェア、2022年
・CD19標的、BCMA標的

世界のCAR T細胞型薬剤市場：用途別、2018年-2023年、2024年-2029年
世界のCAR T細胞型薬剤市場：用途別市場シェア、2022年
・リンパ腫、多発性骨髄腫

世界のCAR T細胞型薬剤市場：地域・国別、2018年-2023年、2024年-2029年
世界のCAR T細胞型薬剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるCAR T細胞型薬剤のグローバル売上、2018年-2023年
・主要企業におけるCAR T細胞型薬剤のグローバル売上シェア、2022年
・主要企業におけるCAR T細胞型薬剤のグローバル販売量、2018年-2023年
・主要企業におけるCAR T細胞型薬剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKite

*************************************************************

・調査・分析レポートの概要
CAR T細胞型薬剤市場の定義
市場セグメント
世界のCAR T細胞型薬剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のCAR T細胞型薬剤市場規模
世界のCAR T細胞型薬剤市場規模：2022年 VS 2029年
世界のCAR T細胞型薬剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのCAR T細胞型薬剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のCAR T細胞型薬剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：CD19標的、BCMA標的
CAR T細胞型薬剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：リンパ腫、多発性骨髄腫
CAR T細胞型薬剤の用途別グローバル売上・予測

・地域別市場分析
地域別CAR T細胞型薬剤市場規模 2022年と2029年
地域別CAR T細胞型薬剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Gilead Sciences、 Bristol-Myers Squibb、 J & J、 JW Therapeutics、 FOSUNKite
...

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
This report aims to provide a comprehensive presentation of the global market for Drugs Based on CAR T-cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs Based on CAR T-cell. This report contains market size and forecasts of Drugs Based on CAR T-cell in global, including the following market information:
Global Drugs Based on CAR T-cell Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs Based on CAR T-cell market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs Based on CAR T-cell include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics and FOSUNKite, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs Based on CAR T-cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs Based on CAR T-cell Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, by Type, 2022 (%)
CD19-targeted
BCMA-targeted
Global Drugs Based on CAR T-cell Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global Drugs Based on CAR T-cell Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs Based on CAR T-cell Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs Based on CAR T-cell revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs Based on CAR T-cell revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs Based on CAR T-cell, market overview.
Chapter 2: Global Drugs Based on CAR T-cell market size in revenue.
Chapter 3: Detailed analysis of Drugs Based on CAR T-cell company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs Based on CAR T-cell in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drugs Based on CAR T-cell Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs Based on CAR T-cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs Based on CAR T-cell Overall Market Size
2.1 Global Drugs Based on CAR T-cell Market Size: 2022 VS 2029
2.2 Global Drugs Based on CAR T-cell Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs Based on CAR T-cell Players in Global Market
3.2 Top Global Drugs Based on CAR T-cell Companies Ranked by Revenue
3.3 Global Drugs Based on CAR T-cell Revenue by Companies
3.4 Top 3 and Top 5 Drugs Based on CAR T-cell Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs Based on CAR T-cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs Based on CAR T-cell Players in Global Market
3.6.1 List of Global Tier 1 Drugs Based on CAR T-cell Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs Based on CAR T-cell Market Size Markets, 2022 & 2029
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type – Global Drugs Based on CAR T-cell Revenue & Forecasts
4.2.1 By Type – Global Drugs Based on CAR T-cell Revenue, 2018-2023
4.2.2 By Type – Global Drugs Based on CAR T-cell Revenue, 2024-2029
4.2.3 By Type – Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs Based on CAR T-cell Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application – Global Drugs Based on CAR T-cell Revenue & Forecasts
5.2.1 By Application – Global Drugs Based on CAR T-cell Revenue, 2018-2023
5.2.2 By Application – Global Drugs Based on CAR T-cell Revenue, 2024-2029
5.2.3 By Application – Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs Based on CAR T-cell Market Size, 2022 & 2029
6.2 By Region – Global Drugs Based on CAR T-cell Revenue & Forecasts
6.2.1 By Region – Global Drugs Based on CAR T-cell Revenue, 2018-2023
6.2.2 By Region – Global Drugs Based on CAR T-cell Revenue, 2024-2029
6.2.3 By Region – Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Drugs Based on CAR T-cell Revenue, 2018-2029
6.3.2 US Drugs Based on CAR T-cell Market Size, 2018-2029
6.3.3 Canada Drugs Based on CAR T-cell Market Size, 2018-2029
6.3.4 Mexico Drugs Based on CAR T-cell Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Drugs Based on CAR T-cell Revenue, 2018-2029
6.4.2 Germany Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.3 France Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.4 U.K. Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.5 Italy Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.6 Russia Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.7 Nordic Countries Drugs Based on CAR T-cell Market Size, 2018-2029
6.4.8 Benelux Drugs Based on CAR T-cell Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Drugs Based on CAR T-cell Revenue, 2018-2029
6.5.2 China Drugs Based on CAR T-cell Market Size, 2018-2029
6.5.3 Japan Drugs Based on CAR T-cell Market Size, 2018-2029
6.5.4 South Korea Drugs Based on CAR T-cell Market Size, 2018-2029
6.5.5 Southeast Asia Drugs Based on CAR T-cell Market Size, 2018-2029
6.5.6 India Drugs Based on CAR T-cell Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Drugs Based on CAR T-cell Revenue, 2018-2029
6.6.2 Brazil Drugs Based on CAR T-cell Market Size, 2018-2029
6.6.3 Argentina Drugs Based on CAR T-cell Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Drugs Based on CAR T-cell Revenue, 2018-2029
6.7.2 Turkey Drugs Based on CAR T-cell Market Size, 2018-2029
6.7.3 Israel Drugs Based on CAR T-cell Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs Based on CAR T-cell Market Size, 2018-2029
6.7.5 UAE Drugs Based on CAR T-cell Market Size, 2018-2029
7 Drugs Based on CAR T-cell Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Drugs Based on CAR T-cell Major Product Offerings
7.1.4 Novartis Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Drugs Based on CAR T-cell Major Product Offerings
7.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Major Product Offerings
7.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J Drugs Based on CAR T-cell Major Product Offerings
7.4.4 J & J Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics Drugs Based on CAR T-cell Major Product Offerings
7.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite Drugs Based on CAR T-cell Major Product Offerings
7.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Drugs Based on CAR T-cell Market Opportunities & Trends in Global Market
Table 2. Drugs Based on CAR T-cell Market Drivers in Global Market
Table 3. Drugs Based on CAR T-cell Market Restraints in Global Market
Table 4. Key Players of Drugs Based on CAR T-cell in Global Market
Table 5. Top Drugs Based on CAR T-cell Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs Based on CAR T-cell Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs Based on CAR T-cell Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs Based on CAR T-cell Product Type
Table 9. List of Global Tier 1 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs Based on CAR T-cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs Based on CAR T-cell Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs Based on CAR T-cell Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs Based on CAR T-cell Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs Based on CAR T-cell Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Drugs Based on CAR T-cell Product Offerings
Table 32. Novartis Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Drugs Based on CAR T-cell Product Offerings
Table 36. Gilead Sciences Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offerings
Table 40. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J Drugs Based on CAR T-cell Product Offerings
Table 44. J & J Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics Drugs Based on CAR T-cell Product Offerings
Table 48. JW Therapeutics Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite Drugs Based on CAR T-cell Product Offerings
Table 52. FOSUNKite Drugs Based on CAR T-cell Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
List of Figures
Figure 1. Drugs Based on CAR T-cell Segment by Type in 2022
Figure 2. Drugs Based on CAR T-cell Segment by Application in 2022
Figure 3. Global Drugs Based on CAR T-cell Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs Based on CAR T-cell Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs Based on CAR T-cell Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs Based on CAR T-cell Revenue in 2022
Figure 8. By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs Based on CAR T-cell Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 16. US Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 20. Germany Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 28. China Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs Based on CAR T-cell Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs Based on CAR T-cell Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite Drugs Based on CAR T-cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ CAR T細胞型薬剤の世界市場見通し2023年-2029年(Drugs Based on CAR T-cell Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

CAR T細胞型薬剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp